Hepatocyte death associated biomarkers:promising prognostic indicators for Hepatitis B virus related

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:ahanyin
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Currently,survival data from Asia on Acute-on-chronic liver failure(ACLF) patients induced by reactivation of hepatitis B virus(HBV-ACLF) are urgently needed to develop novel biomarkers helping determine when treatments such as intensive care alone,artificial liver support,or liver transplantation are optimal.Thus,in this study we aim to identify potential cell death biomarkers that could be of prognostic value in HBVACLF.
其他文献
Background:The EFFORT study have concluded that adjusting treatment strategy is recommended for suboptimal virological responders to telbivudine(LdT) at week 24,adding on adefovir(ADV) can benefit the
会议
Background:This trial is to assess the efficacy and safety of Polyethylene Glycol thymosin alpha1(PEG-Tα1),a new long immunomodulator(Category 1.1 of Chemical Drugs) being developed from Hansoh Pharma
会议
Background:To investigate the course and efficacy of sequential PEG-IFN treatment for poor effect of HBeAg positive chronic hepatitis B patients treated with nucleos(t)ide analogue.
会议
Background:Discuss differences between early cirrhosis and no cirrhosis patients in chronic hepatitis B(CHB)patients at HBV genotypes and nontraumatic indexs commonly used in clinical.
会议
BACKGROUND & AIMS:Traditional Chinese medicine(TCM),Biejiaruangan Compound(BJRGC),containing Carapax trionycis,Cordyceps sinensis and other 9 herbs has been used to treat liver fibrosis for almost two
会议
Background:To investigate the relationship between HBV DNA BCP/PC region quasispecies features with relapse until meeting endpoint criteria in CHB patients with LAM treatment Methods:43 CHB patients l
会议
Background:To investigate the influence of combined antiretrovirus therapy on replication of HBV or HCV and the occurrence of end-stage-liver diseases among HIV/HBV/HCV triple infection patients.
会议
Background:AIM:Intrahepatic cholestasis(IHC) is common in viral hepatitis patients.Although the patients are clinically asymptomatic,the IHC indicators,alkaline phosphatase(ALP) or gamma glutamyltrans
会议
Background:With the successfully inoculation of hepatitis B vaccine in the newborns,HBsAg carrier rate have significantly decreased during the past ten years in China.However,little is known about the
会议
Background:Non-alcoholic fatty liver disease(NAFLD),ranging from nonalcoholic fatty Liver(NAFL) to progressive non-alcoholic steatohepatitis(NASH) and fibrosis,has become an increasingly common health
会议